Table 4.
Gene | Genotype/allele | Prostate cancer patients (n = 101) |
Control group (n = 216) |
P |
---|---|---|---|---|
RAD51
rs1801320 |
GG | 66 | 172 | 0.017 |
GC | 27 | 37 | ||
CC | 8 | 7 | ||
G | 159 | 381 | 0.002 | |
C | 43 | 51 | ||
rs1801321 | GG | 39 | 67 | 0.392 |
TG | 4 | 8 | ||
TT | 58 | 141 | ||
G | 82 | 421 | 0.058 | |
T | 120 | 290 | ||
| ||||
RAD51B
rs10483813 |
TT | 56 | 134 | 0.350 |
TA | 40 | 68 | ||
AA | 5 | 14 | ||
T | 152 | 336 | 0.481 | |
A | 50 | 96 | ||
rs3784099 | GG | 49 | 122 | 0.225 |
GA | 41 | 80 | ||
AA | 11 | 14 | ||
G | 139 | 324 | 0.102 | |
A | 63 | 108 | ||
| ||||
XRCC2
rs3218536 |
GG | 90 | 196 | 0.648 |
GA | 11 | 20 | ||
AA | 0 | 0 | ||
G | 191 | 412 | 0.800 | |
A | 11 | 20 | ||
| ||||
XRCC3
rs861539 |
CC | 54 | 119 | 0.776 |
CT | 34 | 75 | ||
TT | 13 | 22 | ||
C | 142 | 313 | 0.574 | |
T | 60 | 119 |